Healthcare Equity
AXA Framlington Health
Last updated: 2026-03-13
The Verdict
AXA Framlington Health charges an expense ratio of 1.58%. On a $100,000 portfolio, that's $1,580 per year in fees. Supreme.PM's decoded model provides similar exposure at a fraction of the cost, potentially saving $1,330 per year.
Expense Ratio
1.58%
Star Rating
2/ 5
Market Beta
1.02
Supreme.PM Cost
0.25%
Annual platform fee
Fee Analysis
AXA Framlington Health charges 1.58% annually. Supreme.PM offers equivalent exposure for 0.25%, a savings of 1.33 percentage points.
Data sources: Refinitiv Lipper, SEC EDGAR Filings, Supreme.PM Analytics
Past performance does not guarantee future results. Model returns are backtested and may not reflect actual trading conditions.
Related
Healthcare Equity Category
Browse all Healthcare Equity funds
Healthcare Equity Rankings
Top-rated Healthcare Equity funds
Our Methodology
How we decode fund strategies
Pictet-Health
1-star rated
Wellington Global Health Care Equity
2-star rated
Polar Capital Healthcare Opportunities
4-star rated
Invesco Global Health Care Innovation
2-star rated
Goldman Sachs Glo Fut Hlth Care Eq Ptfl Base
2-star rated
Frequently Asked Questions
What is the expense ratio of AXA Framlington Health?
AXA Framlington Health has an expense ratio of 1.58%. Supreme.PM's decoded model provides similar exposure at a significantly lower cost.
How does Supreme.PM replicate AXA Framlington Health?
Supreme.PM uses AI to analyze the fund's holdings and trading patterns, creating a decoded model that tracks the fund's performance.
What are the risks of fund replication?
While our models aim for high correlation, they may not perfectly match the fund's returns due to timing differences in rebalancing, transaction costs, and disclosure delays. Backtested results may not reflect future performance.
Get This Strategy
Start investing with Supreme.PM's decoded model and save on fees while capturing similar returns.